SCHEMBL3726264

SCHEMBL3726264

N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.70
DPP4 P27487 4/20 0.69
DPP8 Q6V1X1 3/20 0.69
DPP9 Q86TI2 3/20 0.69
DPP7 Q9UHL4 3/20 0.69
FAP Q12884 2/20 0.69
LTA4H P09960 5/20 0.63
TACR1 P25103 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5900809 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL29666849 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL6436643 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL4330942 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL3726263 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL31026624 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL7375090 1.00 ACE (0.70) ACEDPP4DPP8DPP9DPP7
SCHEMBL6373910 0.99 ACE (0.69) ACEDPP4DPP8DPP9DPP7
SCHEMBL2879742 0.96 ACE (0.65) ACEDPP4DPP8DPP9DPP7
SCHEMBL2879744 0.96 ACE (0.65) ACEDPP4DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4659591-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT House Foods Group Inc. (JP) 2025-12-10 EP claimed
EP-4659592-A1 FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT House Foods Corporation (JP) 2025-12-10 EP claimed
US-20250336540-A1 METABOLITE PREDICTORS FOR LUNG CANCER JANSSEN PHARMACEUTICA NV (BE) 2025-10-30 US claimed
CN-119296764-A Marker for detecting sensitivity of tumor radiotherapy and screening method and application thereof 福建医科大学附属协和医院 2025-01-10 CN claimed
US-12186312-B2 Sleep improving agent Amino Up Co., Ltd. (JP) 2025-01-07 US claimed
CN-119224161-A Method for detecting various dipeptides in rumen fluid of ruminant 中国科学院亚热带农业生态研究所 2024-12-31 CN claimed
US-20240315296-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING CJ CHEILJEDANG CORPORATION (KR) 2024-09-26 US claimed
CN-115124591-B Spirulina platensis phycocyanin angiotensin converting enzyme inhibitory peptide and preparation method and application thereof 齐鲁工业大学 2024-09-13 CN claimed
CN-115746092-B Spirulina platensis phycocyanin active peptide with antioxidant and anti-aging activities and application thereof 齐鲁工业大学 2024-08-13 CN claimed
WO-2024162422-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT ハウス食品グループ本社株式会社 2024-08-08 WO claimed
CN-115651079-A Elastin peptidase inhibitory peptide and preparation method and application thereof 华南理工大学 2023-01-31 CN claimed
WO-2023277549-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING 씨제이제일제당 (주) 2023-01-05 WO claimed
CN-113201046-B Walnut meal anti-inflammatory peptide FPY and application thereof 北京林业大学 2022-11-15 CN claimed
CN-113173970-B Walnut meal anti-inflammatory peptide FPL and application thereof 北京林业大学 2022-11-15 CN claimed
WO-2022181712-A1 COMPOSITION CONTAINING DECOMPOSED PRODUCTS OF VEGETABLE PROTEIN AND METHOD FOR PRODUCING SAME 株式会社Mizkan Holdings 2022-09-01 WO claimed
WO-2022067445-A1 BIOACTIVE COLLAGEN PEPTIDES, METHOD OF PRODUCTION THEREOF, AND USE THEREOF CORPORATION GENACOL CANADA INC. (CA) 2022-04-07 WO claimed
US-10702571-B2 Materials for cathepsin B enhancement and methods of use THE UNIVERSITY OF NORTH CAROLINA AT PEMBROKE (US) 2020-07-07 US claimed
CN-108929340-A Proline boric acid compound and its preparation method and application 北京大学 2018-12-04 CN claimed
US-20180264071-A1 MATERIALS FOR CATHEPSIN B ENHANCEMENT AND METHODS OF USE THE UNIVERSITY OF NORTH CAROLINA AT PEMBROKE 2018-09-20 US claimed
WO-2017096049-A1 MATERIALS FOR CATHEPSIN B ENHANCEMENT AND METHODS OF USE THE UNIVERSITY OF NORTH CAROLINA AT PEMBROKE (US) 2017-06-08 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10702571-B2 Materials for cathepsin B enhancement and methods of use CTSB, CTSA, CTSE ACE 639/4885DPP4 1614/4885DPP8 1800/4885
US-12186312-B2 Sleep improving agent HSF1, HSPH1, HSPA2 ACE 4551/4885DPP4 4255/4885DPP8 4308/4885
US-20180264071-A1 MATERIALS FOR CATHEPSIN B ENHANCEMENT AND METHODS OF USE CTSB, CTSA, CTSE ACE 639/4885DPP4 1614/4885DPP8 1800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.